{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:35:20Z","timestamp":1782549320006,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T00:00:00Z","timestamp":1233964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00228-009-0620-0","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T07:07:23Z","timestamp":1233990443000},"page":"615-625","source":"Crossref","is-referenced-by-count":107,"title":["Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants"],"prefix":"10.1007","volume":"65","author":[{"given":"Roland","family":"Lennest\u00e5l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Otterblad Olausson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"K\u00e4ll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,7]]},"reference":[{"key":"620_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0002-9378(94)90276-3","volume":"181","author":"E Rey","year":"1994","unstructured":"Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obst Gynecol 181:410\u2013416","journal-title":"Am J Obst Gynecol"},{"key":"620_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1471-0528.1996.tb09662.x","volume":"103","author":"LM McCowan","year":"1996","unstructured":"McCowan LM, Buist RG, North RA et al (1996) Perinatal morbidity in chronic hypertension. Br J Obstet Gynecol 103:123\u2013129","journal-title":"Br J Obstet Gynecol"},{"key":"620_CR3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1067\/mob.2000.107621","volume":"183","author":"BM Sibal","year":"2000","unstructured":"Sibal BM, Caritis SN, Hauth JC et al (2000) Preterm delivery in women with pregestational diabetes or chronic hypertension relative to women with uncomplicated pregnancies. The National Institute of Child Health and Human Development \u2013 Fetal Medicine Units Network. Am J Obst Gynecol 183:1520\u20131524","journal-title":"Am J Obst Gynecol"},{"key":"620_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-3782(01)00181-5","volume":"64","author":"JG Ray","year":"2001","unstructured":"Ray JG, Burrows RF, Burrows E et al (2001) McMaster outcome study of hypertension in pregnancy. Early Hum Dev 64:129\u2013143","journal-title":"Early Hum Dev"},{"key":"620_CR5","doi-asserted-by":"crossref","unstructured":"Abalos E, Duley L, Steyn DW et al (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 1: CD002252. doi: 10.1002\/14651858.CD002252.pub2 .","DOI":"10.1002\/14651858.CD002252.pub2"},{"key":"620_CR6","unstructured":"Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton, MA"},{"key":"620_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","volume":"17","author":"B K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n B, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255\u2013261","journal-title":"Reprod Toxicol"},{"key":"620_CR8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","volume":"354","author":"WO Cooper","year":"2006","unstructured":"Cooper WO, Hernandez-Diaz S, Arbogast P et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. New Engl J Med 354:2443\u20132451","journal-title":"New Engl J Med"},{"key":"620_CR9","unstructured":"National Board of Health and Welfare, Centre for Epidemiology (2003) The Swedish Medical Birth Register \u2013 a summary of content and quality. http:\/\/www.sos.se\/FULLTEXT\/112\/2003-112-3\/2003-112-3.pdf . Accessed May 12, 2008"},{"key":"620_CR10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01719316","volume":"11","author":"B K\u00e4ll\u00e9n","year":"1995","unstructured":"K\u00e4ll\u00e9n B (1995) A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry 1985-1989. Eur J Epidemiol 11:601\u2013606","journal-title":"Eur J Epidemiol"},{"key":"620_CR11","unstructured":"National Board of Health and Welfare, Centre for Epidemiology (2004) Registration of congenital malformations in Swedish health registers. http:\/\/www.socialstyrelsen.se\/Publicerat\/2004\/5120\/2004-112-1.htm . Accessed May 12, 2008"},{"key":"620_CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JRS-2001-263","volume":"14","author":"B K\u00e4ll\u00e9n","year":"2001","unstructured":"K\u00e4ll\u00e9n B, Otterblad Olausson P (2001) Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Safety Med 14:115\u2013119","journal-title":"Int J Risk Safety Med"},{"key":"620_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-3782(00)00125-0","volume":"61","author":"A \u00c5berg","year":"2001","unstructured":"\u00c5berg A, Westbom L, K\u00e4ll\u00e9n B (2001) Congenital malformations among infants whose mothers had gestational or preexisting diabetes. Early Hum Develop 61:85\u201395","journal-title":"Early Hum Develop"},{"key":"620_CR14","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMc061798","volume":"355","author":"AR Scialli","year":"2006","unstructured":"Scialli AR, Lione A (2006) ACE inhibitors and major congenital malformations (letter). New Engl J Med 355:1280","journal-title":"New Engl J Med"},{"key":"620_CR15","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"2005","unstructured":"Briggs GG, Freeman RK, Yaffe SJ (2005) Drugs in pregnancy and lactation, 7th edn. Lippincott Williams and Wilkins, Philadelphia","edition":"7"},{"key":"620_CR16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/tera.1420500606","volume":"50","author":"M Barr Jr","year":"1994","unstructured":"Barr M Jr (1994) Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50:399\u2013409","journal-title":"Teratology"},{"key":"620_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9378(94)90075-2","volume":"171","author":"WJ Harewood","year":"1994","unstructured":"Harewood WJ, Phippard AF, Duggin G et al (1994) Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas). Am J Obstet Gynecol 171:633\u2013642","journal-title":"Am J Obstet Gynecol"},{"key":"620_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006822911586","volume":"176","author":"HS Buttar","year":"1997","unstructured":"Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61\u201371","journal-title":"Mol Cell Biochem"},{"key":"620_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/10408440591007160","volume":"35","author":"S Tabacova","year":"2005","unstructured":"Tabacova S (2005) Mode of action: angiotensin-converting enzyme inhibition\u2014developmental effects associated with exposure to ACE inhibitors. Crit Rev Toxicol 35:747\u2013755","journal-title":"Crit Rev Toxicol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0620-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-009-0620-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0620-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:01:49Z","timestamp":1738933309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-009-0620-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,7]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1007\/s00228-009-0620-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,7]]}}}